About Us

Direct Disease Detection

We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. While other technologies can detect proteins that pass through the blood-brain barrier, they cannot differentiate between healthy proteins and disease-specific proteins that aggregate. Our APEX technology is the first platform that has demonstrated the ability to directly detect – with a simple blood draw – the disease-specific proteins that aggregate and signal the presence of Alzheimer’s disease, Parkinson’s disease and other neurological disorders. These include amyloid beta (Aβ), tau, alpha synuclein (α-synuclein), TDP43, and other protein and non-protein biomarkers.

Our pipeline of innovative, non-invasive technologies has the potential to empower researchers and clinicians with unparalleled insights not available from current tests. Our exceptional expertise in blood-based diagnostics positions us to become a global leader in the field, addressing significant research and clinical gaps, and serving multiple, sizable markets.

​

This important work and our team’s unwavering commitment to achieving our goals is driven by our values. At Sunbird Bio, we are:

​

• Innovative: We are mission driven, unconventional thinkers and problem solvers, motivated by what could be.
   

• Integrous: We are committed to doing what’s right, with humility and accountability to deliver trusted results to patients in need.
   

• Resilient: We are agile and adaptable in our fast paced, dynamic world, demonstrating grit and perseverance daily.
   

• Achieving More Together: We are a diverse team, unified by open communication, collaboration, continuous learning, and respect, creating a safe and supportive environment in which we may all thrive.